SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-14-006104
Filing Date
2014-12-09
Accepted
2014-12-09 13:02:17
Documents
5
Period of Report
2014-12-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctic-8k_20141208.htm 8-K 40622
2 EX-99.1 ctic-ex991_2014120832.htm EX-99.1 18502
3 EX-99.2 ctic-ex992_2014120831.htm EX-99.2 17938
4 GRAPHIC g2014120901133441891.jpg GRAPHIC 14761
5 GRAPHIC g2014120901133530989.jpg GRAPHIC 14753
  Complete submission text file 0001564590-14-006104.txt   119257
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 141274603
SIC: 2834 Pharmaceutical Preparations